Beijing Tiantan Biological Products (SHSE:600161) Other Stockholders Equity: ¥2,804 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600161 Beijing Tiantan Biological Products Corp Ltd SHSE:600161
68 GF Score
Price ¥12.05
GF Value ¥23.01
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Tiantan Biological Products Other Stockholders Equity?

Beijing Tiantan Biological Products SHSE:600161 -2.59% 68 Other Stockholders Equity is ¥2,804 Mil as of Mar. 2026. GuruFocus rates SHSE:600161 with a GF Score™ of 68/100 and a GF Value™ of ¥23.01 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Beijing Tiantan Biological Products's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ¥2,804 Mil.

Beijing Tiantan Biological Products's quarterly Other Stockholders Equity declined from Sep. 2025 (¥2,807 Mil) to Dec. 2025 (¥438 Mil) but then increased from Dec. 2025 (¥438 Mil) to Mar. 2026 (¥2,804 Mil).

Beijing Tiantan Biological Products's annual Other Stockholders Equity increased from Dec. 2023 (¥359 Mil) to Dec. 2024 (¥385 Mil) and increased from Dec. 2024 (¥385 Mil) to Dec. 2025 (¥438 Mil).

Beijing Tiantan Biological Products Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Beijing Tiantan Biological Products's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tiantan Biological Products Other Stockholders Equity Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 350.37 356.19 358.51 384.60 437.81

Beijing Tiantan Biological Products Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,750.82 384.60 2,806.91 437.81 2,804.16
SHSE:600161
68GF Score
Beijing Tiantan Biological Products Corp Ltd SHSE:600161
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tiantan Biological Products Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ¥2,804 Mil mean?
Beijing Tiantan Biological Products (SHSE:600161) has a Other Stockholders Equity of ¥2,804 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Beijing Tiantan Biological Products and its competitors.
Is Beijing Tiantan Biological Products' Other Stockholders Equity too high?
Beijing Tiantan Biological Products' current Other Stockholders Equity is ¥2,804 Mil. Overall, Beijing Tiantan Biological Products has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' Other Stockholders Equity compare to VRTX and REGN?
Beijing Tiantan Biological Products' Other Stockholders Equity of ¥2,804 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Beijing Tiantan Biological Products and its competitors. Beijing Tiantan Biological Products's current Other Stockholders Equity is ¥2,804 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥23.01, compared to a current price of ¥12.05 — trading 47.6% below its estimated fair value. The current Other Stockholders Equity is ¥2,804 Mil. Beijing Tiantan Biological Products' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current Other Stockholders Equity is ¥2,804 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued. The current stock price of ¥12.05 is trading 47.6% below its estimated GF Value™ of ¥23.01. GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.

Key valuation signals for SHSE:600161:

  • Other Stockholders Equity: ¥2,804 Mil
  • GF Value™: ¥23.01 vs. price of ¥12.05 (47.6% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tiantan Biological Products Business Description

Address No. 2, Shuangqiao Road, Chaoyang District, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
68GF Score

Get the complete analysis for SHSE:600161

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.05
Price
¥23.01
GF Value